Status:
COMPLETED
Thrombus and Inflammation Study in Sudden Cardiac DEath
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Sudden Cardiac Death
Acute Myocardial Infarction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Sudden death is a natural death occurring within one hour after the onset of symptoms. It remains a major public health problem and accounts for 5 to 10 % of the annual total mortality ie about 300.00...
Detailed Description
Sudden death is a natural death occurring within one hour after the onset of symptoms. It remains a major public health problem and accounts for 5 to 10 % of the annual total mortality ie about 40 000...
Eligibility Criteria
Inclusion
- Patients with sudden cardiac death without coronary artery occlusion
- Patients with acute myocardial infarction due to coronary artery occlusion
- Patients with stable angina treated with coronary angioplasty
- Written informed consent
- Social security
Exclusion
- Pregnancy
- Small arteries that preclude the use of aspiration devices
- Sudden death without coronary lesions
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT00748111
Start Date
August 1 2008
End Date
December 1 2012
Last Update
December 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Cochin
Paris, France, 75014